Increased expression of the MRP5 gene is associated with exposure to platinum drugs in lung cancer

International Journal of Cancer

Volumn 86, Issue 1, 2000, Pages 95-100

  Oguri, Tetsuya ^a   Isobe, Takeshi ^a   Suzuki, Toshihiro ^b,c   Nishio, Kazuto ^b   Fujiwara, Yasuhiro ^a,d   Katoh, Osamu ^e   Yamakido, Michio ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^e HIROSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; MULTIDRUG RESISTANCE PROTEIN; PLATINUM DERIVATIVE;

ADULT; AGED; ARTICLE; AUTOPSY; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG CANCER; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKOCYTES, MONONUCLEAR; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0034094338     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000401)86:1<95::AID-IJC15>3.0.CO;2-G     Document Type: Article

References (37)

1. BELINSKY, M.G., BAIN, L.J., BALSAKA, B.B., TESTA, J.R. and KRUH, G.D., Characterisation of MOAT-C and MOAT-D, new members of the MRP/ cMOAT subfamily of transporter proteins. J. nat. Cancer Inst., 90, 1735-1741 (1998).
2. BROCK, I., HIPFNER, D.R., NIELSEN, B.S., JENSEN, P.B., DEELEY, R.G., COLE, S.P.C. and SEHESTED, M., Sequential coexpression of the multidrug resistance genes MRP and mdr1 and their products in VP-16 (etoposide)-selected H69 small cell lung cancer cells. Cancer Res., 55, 459-462 (1995).
3. BÜCHLER, M., KÖNIG, J., BROM, M., KARTENBECK, J., SPRING, H., HORIE, T. and KEPRLER, D., cDNA cloning of the hepatocyle canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J. biol. Chem., 271, 15091-15098 (1996).
4. BUNGO, M., FUJIWARA, Y., KASAIIARA, K., NAKAGAWA, K., OHE, Y., SASAKI, Y., IRINO, S. and SAIJO, N., Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplutinum (II) in human non-small cell lung cancer cell lines: relation to DNA damage and repair. Cancer Res., 50, 2549-2553 (1990).
5. CAMPLING, B.G., YOUNG., L.C., BAER, K.A., LAM, Y.M., DEELY, R.G., COLE, S.P.C. and GERLACH, J.H., Expression of the MRP and MDR1 multidrug resistance genes in small cell lung cancer. Clin. Cancer Res., 3, 115-122 (1997).
6. CHEN, Z-S., MUTOH, M., SUMIZAWA, T., FURUKAWA, T., HARAGUCHI, M., TANI, A., SAIJO N., KONDO, T. and AKIYAMA, S., An active efflux system for heavy metals in cisplatin-resistant human KB carcinoma cells. Exp. Cell Res., 240, 312-320 (1998).
7. CHUMAN, Y., CHEN, Z-S., SUMIYAWA, T., FURUKAWA, T., HARAGUCI, M., TAKEBAYASI, Y., NIWA, K., YAMADA, K., AIKOU, T., and AKIYAMA, S., Characterization of the ATP-dependent LTC4 transporter in cisplatin-resistant human KB cells. Biochem. biophys. Res. Comm., 226, 158-165 (1996).
8. FUJII, R., MUTOH, M., SUMIZAWA, T., CHEN. Z-S., YOSHIMURA, A. and AKIYAMA, S., Adenosine triphosphate-dependent transport of leukotriene C4 by membrane vesicles prepared from cisplatin-resistant human epidermoid carcinoma tumor cells. J. nat. Cancer Inst., 86, 1781-1784 (1994).
9. FLENS, M.J., ZAMAN, G.J.R., VAN DER VALK, P., IZQUIERDO, M.A., SCHROEIJERS, A.B., SCHEFFER, G.L., VAN DER GROEP, P., DE HAAS, M., MEIJER, C.J.L.M. and SCHEPER, R.J., Tissue distribution of the multidrug resistance protein. Amer. J. Pathol., 148, 1237-1247 (1996).
10. FUJIWARA, Y., SUGIMOTO, Y., KASAHARA, K., BUNGO, M., YAMAKIDO, M., TEW, K.D. and SAIJO, N., Determinants of drug response in a cisplatin-resistant human lung cancer cell line. Jpn. J. Cancer Res., 81, 527-535 (1990).
11. FUJIWARA, Y., TAKAHASHI, T., YAMAKIDO, M., OBUNE, T., TSUYA, T. and EGORIN, M.J., Re: prediction of carhoplatin clearance from standard morphological and biological patient characteristics (letter). J. nat. Cancer Inst., 89, 260-261 (1997).
12. ISHIKAWA, T., The ATP-dependent glutathione S-conjugate export pump. Trends biochem. Sci., 17, 463-468 (1992).
13. ISHIKAWA, T. and ALI-OSMAN, F., Glutathione-associaled cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. J. biol. Chem., 268, 20116-20125 (1993).
14. ISHIKAWA, T., BAO, J-J., YAMANE, Y. AKIMURA, K., FRINDRICH, K., WRIGHT, C.D. and KUO, M.T., Coordinated induction of MRP/GS-X pump and γ-glutamylcysteine synthetase by heavy metals in human leukemia cells. J. biol. Chem., 271, 14981-14988 (1996).
15. ISHIKAWA, T., WRIGHT, C.D. and ISHIZUKA, H., GS-X pump is functionally overexpressed in cis-diamminedichloroplatinum (II)-resistant human leukemia HL-60 cells and down-regulated by cell differentiation. J. biol. Chem., 269, 29085-29093 (1994).
16. JEDLITSCHKY, G., LEIER, I., BUCHHOLZ, U., CENTER, M. and KEPPLER, D., ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res., 54, 4833-4836 (1994).
17. KAUFFMANN, H.M., KEPPLER, D., KARTENBECK, J. and SCHRENK, D., Induction of cMrp/cMoat gene expression by cisplatin, 2-acetylaminofluorene, or cycloheximine in rat hepatocytes. Hepatology, 26, 980-985 (1997).
18. KIGAWA, J., MINAGAWA, Y., CHENG, X. and TERAKAWA, N., γ-glutamylcysteine synthetase up-regulates glutathione multidrug resistance-associated protein in patients with chemoresistant epithelial ovarian cancer. Clin. Cancer Res., 4, 1737-1741 (1998).
19. KOIKE, K., KAWABE, T., TANAKA, T., TOH, S., UCHIUMI, T., WADA, M., AKIYAMA, S., ONO, M. and KUWANO, M., A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells. Cancer Res., 57, 5475-5479 (1997).
20. KOOL, M., DE HAAS, M., SCHEFFER, G.L., SCHEPER, R.J., VAN EUK, M.J.T., JUIJN, J.A., BAAS, F. and BORST, P., Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5 homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res., 57, 3537-3547 (1997).
21. KOOL, M., VAN DER LINDEN, M., DE HAAS, M., BAAS, F. and BORST, P., Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells. Cancer Res., 59, 175-182 (1999).
22. KUO, M.T., BAO, J-J., CURLEY, S.A., IKEGUCHI, M., JOHNSTON, D.A. and ISHIKAWA, T., Frequent coordinated overexpression of the MRP/GS-X pump and γ-glutamylcysteine synthetase genes in human colorectal cancers. Cancer Res., 56, 3642-3644 (1996).
23. KUROKAWA, H., ISHIDA, T., NISHIO, K., ARIOKA, H., SATA, M., FUKUMOTO, H., MIURA, M. and SAIJO N., γ-glutamylcysteine synthetase gene overexpression results in increased activity of the ATP-dependent glulathione S-conjugate export pump and cisplatin resistance. Biochem. biophys. Res. Comm., 216, 258-264 (1995)
24. LONGHURST, T.J., O'NEILL, G.M., HARVIE, R.M. and DAVEY, R.A., The anthracycline resistance-asociated (ara) gene, a novel gene associated with multidrug resistance in a human leukaemia cell line. Brit. J. Cancer, 74, 1331-1335 (1996).
25. MADON, J., ECKHARDT, U., GERLOFF, T., STIEGER, B. and MEIER, P.J., Functional expression of the rat liver canalicular isoform of the multidrug resistance-associated protein. FEBS Lett., 406, 75-78 (1997).
26. MIYAZAKI, M., FUJIWARA, Y., ISOBE, T., YAMAKIDO, M., TAKASHI, K. and MIYAZAKI, H., The relationship between carboplatin AUC and serum thrombopoietin kinetics in patients with lung cancer. Anticancer Res., 19, 667-670 (1999).
27. MIYAZAKI, M., FUJIWARA, Y., TAKAHASHI, T., ISOBE, T., OHUNE, T., TSUYA, T. and YAMAKIDO, M., Limited-sampling models for estimation of the carboplatin area under the curve. Anticancer Res., 17, 4571-4576 (1997).
28. MÜLLER, M., MEIJER, C., ZAMAN, G.J.R., BORST, P., SCHEPER, R.J., MULDER, N.H., DE VRIES, E.G.E, and JANSEN, P.L.M., Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc. nat. Acad. Sci. (Wash.), 91, 13033-13037 (1994).
29. OGURI, T., FUJIWARA, Y., ISOBE, T., KATOH, O., WATANABE, H. and YAMAKIDO, M., Expression of γ-glutamylcysteine synthetase (γ-GCS) and multidrug resistance-associated protein (MRP), but not human canalicular multispecific organic anion transporter (cMOAT), genes correlates with exposure of human lung cancers to platinum drugs. Brit. J. Cancer, 77, 1089-1096 (1998).
30. OGURI, T., FUJIWARA, Y., MIYAZAKI, M., TAKAHASHI, T., KURATA, T., YOKOZAKI, M., OHASHI, N., ISOBE, T., KATOH, O. and YAMAKIDO, M., Induction of γ-glutamylcysteine synthetase gene expression by platinum drugs in peripheral mononuclear cells of lung cancer patients. Ann. Oncol., 10, 455-460 (1999).
31. PULASKI, L., JEDLITSCHKY, G., LEIER, I., BUCHHOLZ, U. and KEPPLER, D., Identification of the multidrug-resistance protein (MRP) as the glutathione-S-conjugate export pump of erythrocytes. Europ. J. Biochem., 241, 644-648 (1996).
32. SAXENA, M. and HENDERSON, G.B., MOAT4, a novel multispecific organicanion transporter for glucronides and mercapturates in mouse L1210 cells human erythrocytes. Boichem. J., 320, 273-281 (1996).
33. SUZUKI, T., SASAKI, H., KUH, H-J., AGUI, M., TATSUMI, Y., TANABE, S., TERADA, M., SAIJO, N. and NISHIO, K., A detail structure analysis on both human MRP5 and mouse mrp5 transcripts. Gene (2000). (In press).
34. SUZUKI, T., NISHIO, K., SASAKI, H., KUROKAWA, H., SAITO-OHARA, F., IKEUCHI, T., TANABE, S., TERADA, M. and SAIJO, N., cDNA cloning of a short type of multidrug resistance protein homologue, SMRP, from a human lung cancer cell line. Biochem. biophys. Res. Comm., 238, 790-794 (1997).
35. TANIGUCHI, K., WADA, M., KOHNO, K., NAKAMURA, T., KAWABE, T., KAWAKAMI, M., KAGOTANI, K., OKUMURA, K., AKIYAMA, S. and KUWANO, M., A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res., 56, 4124-4129 (1996).
36. TOTHILL, P., KLYS, H.S., MATHESON, L.M., MCKAY, K. and SMITH, J.F., The long-term retention of platinum in human tissues following the administration of cisplatin or carboplatin for cancer chemotherapy. Europ. J. Cancer, 28, 1358-1361 (1992).
37. ZAMAN, G.J.R., LANKELMA, J., VAN TELLINGEN, O., BEIJNEN, J., DEKKER, H., PAULUSMA, C.C., OUDE ELPERICK, R.P.J., BAAS, F. and BORST, P., Role of glutathione in the export of compounds from cells by multidrug-resistance-associated protein. Proc. nat. Acad. Sci. (Wash.), 92, 7690-7694 (1995).